The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations

被引:57
|
作者
Kol, A [1 ]
Libby, P [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Cardiovasc Div,Vasc Med & Atherosclerosis Unit, Boston, MA 02115 USA
关键词
D O I
10.1016/S1050-1738(98)00010-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three infectious agents have recently gained considerable interest as potential pathogens in atherosclerosis and in its clinical manifestations: herpes simplex virus, cytomegalovirus, and Chlamydia pneumoniae. Chronic and often asymptomatic infections with these agents occur widely in the general population. These pathogens may affect atherosclerosis either directly or indirectly. Direct effects on vascular wall cells might include cell lysis, transformation, lipid accumulation, proinflammatory changes, and augmentation of procoagulant activity. Indirect systemic effects may involve induction of acute-phase proteins, establishment of a prothrombotic state, hemodynamic stress caused by tachycardia, increased cardiac output, or a regional inflammatory activation in response to systemic endotoxemia and cytokinemia. The effects of microbial infection, usually in combination with other risk factors (for example, smoking, hyperlipidemia, family history), might promote atherogenesis and eventually trigger acute coronary events. (C) 1998 Elsevier Science inc.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 27 条
  • [21] Seasonal Dynamics of Cattle Thelaziasis in Northern Trans-Ural Region and Pathogenetic Mechanisms of its Clinical Manifestations
    Glazunova, Larisa A.
    Glazunov, Yuri, V
    Ergashev, Abduvahob A.
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2020, 13 (04): : 1854 - 1859
  • [22] The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
    Tajbakhsh, Amir
    Khorrami, Mohammad Sadegh
    Hassanian, Seyed Mahdi
    Aghasizade, Malihe
    Pasdar, Alireza
    Maftouh, Mina
    Tabatabai, Ehsan
    Parizadeh, Seyed Mohammad Reza
    Fazeli, Mostafa
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    Avan, Amir
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (37) : 5730 - 5737
  • [23] A novel aspect may explain the mechanisms of pathogenicity of rheumatic fever, a multifactorial, autoimmune, infectious and inflammatory disorder which "licks the joints and bites the heart": A working hypothesis
    Feldman, Mark
    Ginsburg, Isaac
    MEDICAL HYPOTHESES, 2020, 144
  • [24] Basic pharmacological mechanisms and clinical evidence of the efficacy of hochuekkito against infectious diseases and its potential for use against COVID-19
    Takayama, Shin
    Kikuchi, Akiko
    Makino, Toshiaki
    Kainuma, Mosaburo
    Namiki, Takao
    Ito, Takashi
    TRADITIONAL & KAMPO MEDICINE, 2021, 8 (01) : 3 - 21
  • [25] Dimethyl Fumarate Exerts Selective Effects on Key B Cell Subsets and IgG Levels Which May Contribute to its Therapeutic Benefit in MS While Maintaining Protective Humoral Immunity
    Bar-Or, Amit
    Giuliani, Fabrizio
    Mao-Draayer, Yang
    Zamvil, Scott
    Parks, Becky
    Chen, Chongshu
    Mehta, Devangi
    Fam, Sami
    NEUROLOGY, 2019, 92 (15)
  • [26] Preservation of cell-survival mechanisms by the presenilin-1 K239N mutation may cause its milder clinical phenotype
    Sarroca, Sara
    Molina-Martinez, Patricia
    Areste, Cristina
    Etzrodt, Martin
    Garcia de Frutos, Pablo
    Gasa, Rosa
    Antonell, Anna
    Luis Molinuevo, Jose
    Sanchez-Valle, Raquel
    Saura, Carlos A.
    Llado, Albert
    Sanfeliu, Coral
    NEUROBIOLOGY OF AGING, 2016, 46 : 169 - 179
  • [27] Monocyte chemotactic protein (MCP)-1 (CCL2) and its receptor (CCR2) are elevated in chronic heart failure facilitating lung monocyte infiltration and differentiation which may contribute to lung fibrosis
    Puukila, Stephanie
    Lawrence, Mark D.
    De Pasquale, Carmine G.
    Bersten, Andrew D.
    Bihari, Shailesh
    McEvoy-May, James
    Nemec-Bakk, Ashley
    Dixon, Dani-Louise
    CYTOKINE, 2023, 161